CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Open-market buy Director bought 174,967 shares at $7.41 ($1,296,505)
- 4 Other acquisition Director acquired 115,315 shares (other)
- 4 Other acquisition Director acquired 584 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Planned sale MOATAZEDI DAVID sold 6,110 shares at $8.47 ($51,752)
- 4 Open-market sale MOATAZEDI DAVID sold 64,211 shares at $8.47 ($543,797)
- 4 Open-market sale Avelar Rui sold 14,906 shares at $8.47 ($126,237)
- 4 Open-market sale 10% owner sold 1,850,000 shares at $8.40 ($15,540,000)
- 4 Open-market sale 10% owner sold 2,187,511 shares at $8.50 ($18,593,844)
- 4 Open-market sale 10% owner sold 37,043 shares at $11.04 ($408,955)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Avelar Rui acquired 97,642 shares (grant or award)
- 4 Grant or award MOATAZEDI DAVID acquired 187,927 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 62,642 shares (grant or award)
Page 5 of 13 · 252 filings